PRKDC and adult T-cell leukemia/lymphoma: With respect to T-cell lymphomas, the prevalence of DSBs and overreliance on NHEJ in Adult T-cell leukemia lymphoma (ATLL) makes it an attractive target for DNA PK inhibition (69, 70).